Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07659873

Advancing Online Psychology Tools for Chronic Pain

Chronic pain affects more than 20% of Canadians and is associated with significant impacts on physical function, mental health, and quality of life. Despite efforts to improve access to multidisciplinary pain care through centralized referral systems, many patients continue to experience prolonged wait times before receiving treatment.

This study evaluates a self-guided digital psychological intervention designed to support chronic pain self-management during the waiting period for specialized pain care. The intervention was developed through a collaboration between the Transitional Pain Service and ManagingLife and aims to improve access to evidence-based psychological support, enhance self-management skills, and reduce pain-related distress among individuals living with chronic pain.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Fibromyalgia Chronic Pelvic Pain Syndrome Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neuromuscular Diseases Rheumatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Women's College Hospital

Toronto, Ontario, M5S 1B2, Canada

About this study

The Advancing Online Psychology Tools for Chronic Pain (ADOPT-CP) intervention provides participants with access to the Manage My Pain (MMP) platform, including a self-guided Acceptance and Commitment Therapy (ACT)-based digital psychology program and Solace, an artificial intelligence (AI)-enabled conversational support tool for chronic pain. Together, these tools are designed to support pain self-management, emotional coping, and engagement in care.

This study will evaluate the feasibility, acceptability, and preliminary clinical effects of the ADOPT-CP intervention among individuals waiting to access multidisciplinary chronic pain services through the Toronto Academic Pain Medicine Institute (TAPMI). The intervention aims to provide accessible psychological support and self-management resources during the waiting period for specialized pain care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be deemed to have capacity to provide informed consent;
  • Must sign and date the informed consent form;
  • Must state willingness to comply with all study procedures;
  • Must be at least 18 years of age;
  • Must be referred to TAPMI;
  • Must have either fibromyalgia or chronic pelvic pain
  • Must be on the waitlist at TAPMI;
  • Must have access to a device that can connect to the Internet with access to email.

Exclusion criteria

  • Currently engaged in psychotherapy or engaged in psychotherapy within the last month at the time of enrolment;
  • Unable to read, understand, or communicate in English sufficiently to provide informed consent and complete the study procedures and questionnaires;
  • Has active serious mental illness or psychiatric instability that, in the opinion of the research team, may impair the ability to safely participate in the study or to provide informed consent (e.g., active psychosis, active mania);
  • Has a visual, auditory, or other functional impairment that would prevent independent access to and use of the digital intervention and study procedures on an internet-enabled device.

Treatment and study plan

Digital psychology intervention (ADOPT-CP)

Other

The intervention, Manage My Pain (MMP), is a clinically validated app-based platform that supports individuals with chronic pain in self-managing their symptoms and improving communication and engagement with their care team.

Reminder Emails

Other

Weekly emailed pain self-management resources introduced during the Toronto Academic Pain Medicine Institute (TAPMI) orientation

Primary outcomes

  1. Trial feasibility

    Time frame: 10 weeks

    Measured according to the CONSORT criteria and include: eligibility rate, recruitment rate, retention rate, measure completion, absence of or minor adverse events.

  2. Engagement with the digital ADOPT-CP intervention

    Time frame: 10 weeks

    Measured via MMP app analytics (usage rates, completion of psychology program, etc.)

  3. Acceptability and Appropriateness of the ADOPT-CP intervention

    Time frame: 10 weeks

    The Treatment Evaluation Inventory-Short Form (TEI-SF) is a self-report measure assessing the acceptability and perceived appropriateness of a treatment or intervention, with higher scores indicating greater treatment acceptability.

  4. Acceptability and Adherence of the ADOPT-CP intervention

    Time frame: 10 weeks

    The Treatment Acceptability/Adherence Scale (TAAS) is a self-report measure assessing perceived acceptability of an intervention and anticipated or actual adherence, with higher scores indicating greater acceptability and adherence.

  5. Experience using the ADOPT-CP intervention

    Time frame: 14 weeks

    a semi-structured interview guide will be used to explore participant experiences, barriers and facilitators to use, acceptability, engagement, and opportunities to refine the digital intervention prior to a larger trial.

Secondary outcomes

  1. Quality of Life and Pain Interference

    Time frame: 10 weeks

    Modified PROMIS-29 Health Domains (Quality of Life and Pain Interference 8a): A validated patient-reported outcome system assessing the impact of health conditions on physical, mental, and social functioning.

    Higher scores indicate greater pain interference and worse health-related quality of life, while lower scores indicate better functioning and quality of life.

  2. Pain Acceptance

    Time frame: 10 weeks

    Measured by the Chronic Pain Acceptance Questionnaire-Short Form: A validated self-report measure of acceptance of chronic pain.

    Higher scores indicate greater acceptance of chronic pain, including continued activity engagement and reduced avoidance of pain-related experiences.

  3. Psychological Flexibility

    Time frame: 10 weeks

    Measured by the Acceptance and Action Questionnaire-II (AAQ-II): A validated self-report measure of psychological inflexibility and experiential avoidance.

    Higher scores indicate greater psychological inflexibility and experiential avoidance, while lower scores indicate greater psychological flexibility.

  4. Kinesiophobia

    Time frame: 10 weeks

    Measured by the Tampa Scale of Kinesiophobia (TSK): a validated self-report questionnaire used to assess fear of movement and fear of re-injury. Higher scores indicate greater fear of movement.

  5. Pain Resiliency

    Time frame: 10 weeks

    Measured by the Pain Resiliency Scale: Measures how well a person can adapt and maintain function despite chronic pain.

    Higher scores indicate greater resilience in coping with chronic pain, while lower scores indicate reduced adaptive coping.

Study contacts

Contact information is provided by the study sponsor or research team.

Adriano Nella, MSc

CONTACT

[email protected]

416-323-6400 ext. 5977

Didem Bozak

CONTACT

[email protected]

416-323-6008

Sponsors and collaborators

Lead sponsor

Women's College Hospital

Other

Registry information

Official study title

Advancing Online Psychology Tools for Chronic Pain (ADOPT-CP): Feasibility of a Scalable Digital Psychology Intervention and AI-Powered Support for Patients on the Waitlist for Pain Services

Acronym: ADOPT-CP

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jun 22, 2026
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.